Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report
Introduction: Hepatocellular carcinoma (HCC) is by far the leading malignant indication for liver transplantation (LT). Few other malignancies, including cholangiocellular carcinoma (CCC), metastases from neuroendocrine tumors (NET), and sarcomas of the liver (LSAR), also are commonly accepted indic...
Guardado en:
Autores principales: | Philipp Houben, Simon Schimmack, Christian Unterrainer, Bernd Döhler, Arianeb Mehrabi, Caner Süsal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4d00917443b4a05b9abb70a5b6550d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The predictive role of preoperative serum glutamate dehydrogenase levels in microvascular invasion and hepatocellular carcinoma prognosis following liver transplantation—a single center retrospective study
por: Jinlong Gong, et al.
Publicado: (2021) -
Análisis del sistema de alistamiento y priorización para trasplante hepático de adultos en Chile
por: Wolff,Rodrigo, et al.
Publicado: (2020) -
Seminal vesicle mass: An unusual site for metastatic hepatocellular carcinoma after orthotopic liver transplant
por: Diana A. Aponte-Colon, et al.
Publicado: (2022) -
Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size
por: Hsin-Rou Liang, et al.
Publicado: (2021) -
Risk Factors of Pleural Effusion Following Pediatric Liver Transplantation and the Perioperative Outcomes
por: Thirapattaraphan C, et al.
Publicado: (2020)